Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Founder, Gilt Groupe
Vice president, chief strategy and operating officer of the Texas Medical Center
Professor, Michigan State University
Malaria endangers the health of up to 40 percent of the world’s population and kills up to a million children each year. Elizabeth A. Winzeler, a longtime malaria research scientist now in the Department of Pediatrics at U.C. San Diego School of Medicine, will provide an overview concerning several new chemotypes for the treatment of malaria. Some of these compounds are now in clinical trials, as well as a handful of new chemically-validated anti-malarial drug targets. More information and online registration is here.